UNICANCER - Lyon, Centre Léon-Bérard
Welcome,         Profile    Billing    Logout  
 14 Trials 
10 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
BRAHMI, Mehdi
TORNADO, NCT04968106: Neoadjuvant Chemotherapy and Retifanlimab in Patients With Selected Sarcomas

Recruiting
2
66
Europe
Doxorubicin, Ifosfamide, INCMGA00012, Retifanlimab
Institut Bergonié, Incyte Biosciences International Sàrl
Resectable Sarcoma
03/25
10/27
FIH, NCT04104776 / 2020-004952-14: A Study of CPI-0209 in Patients With Advanced Solid Tumors and Lymphomas

Recruiting
1/2
210
Europe, US, RoW
CPI-0209
Constellation Pharmaceuticals
Advanced Solid Tumor, Diffuse Large B Cell Lymphoma, Lymphoma, T-Cell, Mesothelioma, Malignant, Prostatic Neoplasms, Castration-Resistant, Endometrial Cancer, Ovarian Clear Cell Carcinoma
12/25
03/26
SPARTO, NCT05210413: Spartalizumab and Low-dose PAzopanib in Refractory or Relapsed Solid TumOrs of Pediatric and Adults

Recruiting
1/2
59
Europe
Spartalizumab in Pediatric cohort, Low-dose Pazopanib in Pediatric Cohort, Spartalizumab in Adult cohort, Low-dose Pazopanib in Adult Cohort
University Hospital, Bordeaux, National Cancer Institute, France, Fondation ARC, Novartis
Refractory or Recurrent Solid Tumor
11/26
11/27
TRAHD, NCT03714958: Trametinib + HDM201 in CRC Patients With RAS/RAF Mutant and TP53 Wild-type Advanced/Metastatic Colorectal Cancer Mutant and TP53 Wild-type

Completed
1
12
Europe
HDM201, Trametinib
Centre Leon Berard, Novartis
Colorectal Cancer, Advanced Cancer, Metastatic Cancer
09/23
09/23
NCT03715933: Phase 1 Study of INBRX-109 in Subjects with Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Recruiting
1
321
Europe, US
INBRX-109, Carboplatin, Cisplatin, Pemetrexed, 5-fluorouracil, Irinotecan, Temozolomide
Inhibrx Biosciences, Inc
Colorectal Adenocarcinoma, Ewing Sarcoma
06/26
12/26
NCT04936178: A Study of NB003 in Patients With Advanced Malignancies

Recruiting
1
258
Europe, US, RoW
NB003 tablets
Ningbo Newbay Technology Development Co., Ltd
Advanced Solid Tumor
07/25
12/25
MEDISARC-SBRT, NCT05821231: Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma

Recruiting
1
20
Europe
SBRT + MEDI5752
Institut Claudius Regaud, National Cancer Institute, France, AstraZeneca
Soft Tissue Sarcoma
11/27
11/27
RNASARC, NCT03375437: - Molecular Screening Program of Soft Tissue Sarcomas With Complex Genomic Profile to Detect NTRK1/2/3, ROS1 or ALK Gene Fusions.

Active, not recruiting
N/A
376
Europe
Blood and tumor samples
Centre Leon Berard, Hoffmann-La Roche
Soft Tissue Sarcoma, Advanced Cancer, Metastatic Cancer
12/24
12/25
PASCA, NCT04671693: A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.

Recruiting
N/A
858
Europe
PASCA intervention
Centre Leon Berard, Malakoff-Humanis, Fondation Apicil, Fédération Leucémie Espoir, Biogaran, Le défi Anthony, Novartis, Roche Pharma AG
Late Effects, Testicular Germ Cell Tumor Mixed, Non-Metastatic Breast Carcinoma, Soft Tissue Sarcoma, Adult, Stage IIC, Osteosarcoma, Ewing's Sarcoma, Acute Myeloid Leukemia, Hodgkin Disease, Non Hodgkin Lymphoma
01/28
04/28
AVIATOR2020, NCT04927260: French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients

Active, not recruiting
N/A
25
Europe
Patient treated by Avapritinib in real life
Centre Leon Berard, Blueprint Medicines Corporation
GIST, GIST, Malignant, PDGFR-Alpha D842V
04/24
12/24

Download Options